DrugPatentWatch Database Preview
Biologic Patents Expiring in 2022
Biologic Patents With Estimated Expirations in 2022
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | Schering Corporation (Kenilworth, NJ) | 2022-09-23 | RX | search | |
Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | Sonus Pharmaceuticals, Inc. (Bothell, WA) | 2022-07-16 | RX | search | |
Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | The Regents of the University of California (Oakland, CA) | 2022-06-24 | RX | search | |
Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | Schering Corpoartion (Kenilworth, NJ) | 2022-09-04 | RX | search | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |